Cargando…
Transdermal Asenapine in Schizophrenia: A Systematic Review
BACKGROUND: Asenapine is a novel antipsychotic that has demonstrated efficacy in controlling psychosis in schizophrenia and mania in bipolar illness. It must be administered as a sublingual formulation because it is nearly completely metabolized in the first pass through the liver. Recently, a trans...
Autores principales: | Carrithers, Brennan, El-Mallakh, Rif S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468370/ https://www.ncbi.nlm.nih.gov/pubmed/32943849 http://dx.doi.org/10.2147/PPA.S235104 |
Ejemplares similares
-
Review of depot aripiprazole for schizophrenia
por: Motiwala, Farha Bilal, et al.
Publicado: (2013) -
Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts, Rona Jeannie, et al.
Publicado: (2016) -
Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
por: Kidambi, Neil, et al.
Publicado: (2023) -
Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070)
por: Suzuki, Katsumi, et al.
Publicado: (2021) -
Role of sublingual asenapine in treatment of schizophrenia
por: Citrome, Leslie
Publicado: (2011)